Sharon Schlick
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novo Nordisk at 25.2% of the total. Reporting peaked in 2021 at $582 and has fallen 55.5% since, to $259 in 2023.
Across 79 payments — averaging $15.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$312
- Bayer$140
- AbbVie$101
- Eisai Inc.$70
- Boehringer Ingelheim$61
- Novartis$60
- plus $492 from 17 others
What the payments were for
- Food & beverage$1,236100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $312 |
| Bayer | 8 | $140 |
| AbbVie | 7 | $101 |
| Eisai Inc. | 5 | $70 |
| Boehringer Ingelheim | 4 | $61 |
| Novartis | 4 | $60 |
| GSK | 4 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| AstraZeneca | 4 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Corcept Therapeutics | 1 | $24 |
| Dexcom, Inc. | 1 | $24 |
| Corium, LLC | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Merck | 1 | $13 |
| PBG Puerto Rico LLC | 1 | $12 |
How this compares
$1,236 in reported general payments places this provider in the 60th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $123 |
| Fluticasone Propionate | 11 | $96 |
Paid to pharmacies, not to this prescriber.
Other medical in Perry
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.